BioCentury
ARTICLE | Clinical News

QuatRx preclinical data

October 2, 2006 7:00 AM UTC

In primates, QRX-431 reduced LDL cholesterol and lipoprotein levels. The drug also demonstrated a weight reduction in 7 days and did not affect heart rate. ...